Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP for Diuretic Resistance After Cardiac Surgery
NCT07086287Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Aug 2025
- Primary completion
- Nov 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of nesiritide in Diuretic resistance and Fluid overload (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Incidence of Renal Replacement Therapy. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
nesiritide
03
Conditions
Diuretic resistanceFluid overload
Beyond the preview
Go deeper on NCT07086287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07086287.